4
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0001140361-17-046253
President & CEO sold 20,000 shares at $45.99 ($919,800)
- President & CEO acquired 20,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Abdun-Nabi Daniel President & CEO | 2017-12-13 | Option exercise | +20,000 | $14.44 | $288,800 | 224,134 | D: show line 1 in the form |
| Abdun-Nabi Daniel President & CEO | 2017-12-13 | Sale | −20,000 | $45.99 | $919,800 | 204,134 | D: show line 2 in the form |
| Open-market sales · 20,000 sh · avg $45.99 · $919,800 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Abdun-Nabi Daniel President & CEO | 2017-12-13 | Option exercise · Stock Option (Right to Buy) | −20,000 | 21,906 | D: show line 3 in the form |
Loading xslF345X03/doc1.xml…